Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Genmab A/S
DUS:GE9
Genmab A/S
DUS:GE9
Price:
473.4
EUR
-3.29%
Market Closed
Market Cap:
€31B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Genmab A/S
DUS:GE9
|
DK |
|
H
|
Halma PLC
DUS:H11
|
UK |
|
Novartis AG
SIX:NOVNEE
|
CH |
|
N
|
Novartis AG
SWB:NOT
|
CH |
|
P
|
Philip Morris International Inc
XMUN:4I1
|
US |
|
A
|
Atlas Arteria Group
F:M82
|
AU |
Wall St Price Targets
GE9 Price Forecast
Based on 19 analysts
Based on 19 analysts
+15% Upside
from
€473.4
today
Genmab A/S (GE9)’s 12-month stock price forecast through November 2027 has a consensus target of €542.56, implying 15% upside. The forecast is based on price targets from 19 Wall Street analysts.
GE9 Analyst Rating
No ratings yet
No ratings yet
Genmab A/S Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GE9's stock price target?
Price Target
542.56
EUR
542.56
EUR
According to Wall Street analysts, the average 1-year price target for GE9 is 542.56 EUR with a low forecast of 185.71 EUR and a high forecast of 624.16 EUR.
What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Genmab A/S?
Projected CAGR
7%
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%
10%
The compound annual growth rate for Operating Income over the next 8 years is 10%.
What is the Pre-Tax Income forecast for Genmab A/S?
Projected CAGR
20%
20%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 20%.
What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%
12%
The compound annual growth rate for Net Income over the next 8 years is 12%.
